ArticleBlood advances2022
Momelotinib is a highly potent inhibitor of FLT3-mutant AML.
Mohammad Azhar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleBlood advances2022
Mohammad Azhar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.